(Q30432136)

English

Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 June 2017

Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization (English)

1 reference

Europe PubMed Central

21 June 2017

1 reference

based on heuristic

inferred from title

7

object named as

Dimmock NJ

1 reference

Europe PubMed Central

21 June 2017

author name string

Durrani Z

1

1 reference

Europe PubMed Central

21 June 2017

McInerney TL

2

1 reference

Europe PubMed Central

21 June 2017

McLain L

3

1 reference

Europe PubMed Central

21 June 2017

Jones T

4

1 reference

Europe PubMed Central

21 June 2017

Bellaby T

5

1 reference

Europe PubMed Central

21 June 2017

Brennan FR

6

1 reference

Europe PubMed Central

21 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 1998

1 reference

Europe PubMed Central

21 June 2017

Journal of Immunological Methods

1 reference

Europe PubMed Central

21 June 2017

220

1 reference

Europe PubMed Central

21 June 2017

93-103

1 reference

Europe PubMed Central

21 June 2017

1-2

1 reference

Europe PubMed Central

21 June 2017

Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

The expression of hybrid HIV:Ty virus-like particles in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Nasal delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Cellular immune factors associated with mother-to-infant transmission of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Plant-derived vaccine protects target animals against a viral disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Genetic vaccination: the advantages of going naked

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Expression of an animal virus antigenic site on the surface of a plant virus particle

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900145-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-1759(98)00145-8

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30432136&oldid=2107489389"